Alzheimer’s loci: epigenetic associations and interaction with genetic factors

We explore the role of DNA methylation in Alzheimer's disease (AD). To elucidate where DNA methylation falls along the causal pathway linking risk factors to disease, we examine causal models to assess its role in the pathology of AD.

• Publication year

  2015

• Venue

  Annals of Clinical and Translational Neurology

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/acn3.201PMID 26125039PMCID 4479524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci

  2014cited by this paper
• ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status.

  2013cited by this paper
• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

  2013cited by this paper
• Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray

  2013cited by this paper
• Charting a dynamic DNA methylation landscape of the human genome

  2013cited by this paper
• Genetic susceptibility for Alzheimer disease neuritic plaque pathology.

  2013cited by this paper
• Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

  2013cited by this paper
• A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline.

  2012cited by this paper
• Novel late-onset Alzheimer disease loci variants associate with brain gene expression

  2012cited by this paper
• A genome-wide scan for common variants affecting the rate of age-related cognitive decline.

  2012cited by this paper
• Overview and findings from the religious orders study.

  2012cited by this paper
• A coding variant in CR1 interacts with APOE-1 4 to influence cognitive decline

  2012cited by this paper
• Overview and findings from the rush Memory and Aging Project.

  2012cited by this paper
• Alzheimer disease susceptibility loci: evidence for a protein network under natural selection.

  2012cited by this paper
• Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease

  2011influential reference
• Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites

  2011cited by this paper
• Faculty Opinions recommendation of Mapping and analysis of chromatin state dynamics in nine human cell types.

  2011cited by this paper
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease

  2011cited by this paper
• CR1 is associated with amyloid plaque burden and age‐related cognitive decline

  2011cited by this paper
• Genome-wide analysis of genetic loci associated with Alzheimer disease.

  2010cited by this paper
• Dementia Revealed: Novel Chromosome 6 Locus for Late-Onset Alzheimer Disease Provides Genetic Evidence for Folate-Pathway Abnormalities

  2010cited by this paper
• Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

  2009influential reference
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009influential reference
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

  2009cited by this paper
• Genome-wide association studies in Alzheimer's disease.

  2009cited by this paper
• The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study.

  2006cited by this paper
• About the authors

  2004cited by this paper
• Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

  2003cited by this paper
• Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer’s disease

  2003cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper

• The complement cascade in Alzheimer’s disease: modern implications of an ancient immune protagonist

  2025influential citation
• Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer's diseases.

  2025cites this paper
• DNA Methylation in Alzheimer's Disease.

  2024cites this paper
• ABCA7-Associated Clinical Features and Molecular Mechanisms in Alzheimer’s Disease

  2023cites this paper
• Utility of DNA Methylation as a Biomarker in Aging and Alzheimer’s Disease

  2023cites this paper
• Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

  2023cites this paper
• Altered DNA methylome profiles of blood leukocytes in Chinese patients with mild cognitive impairment and Alzheimer’s disease

  2023cites this paper
• Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

  2023cites this paper
• Bioinformatics pipeline to guide late‐onset Alzheimer's disease (LOAD) post‐GWAS studies: Prioritizing transcription regulatory variants within LOAD‐associated regions

  2022cites this paper
• Distinct sex-specific DNA methylation differences in Alzheimer’s disease

  2022cites this paper
• Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease

  2022cites this paper
• Cross-tissue meta-analysis of blood and brain epigenome-wide association studies in Alzheimer's disease

  2022cites this paper
• Sex dependent glial-specific changes in the chromatin accessibility landscape in late-onset Alzheimer’s disease brains

  2021cites this paper
• PathwayMultiomics: An R Package for Efficient Integrative Analysis of Multi-Omics Datasets With Matched or Un-matched Samples

  2021cites this paper
• Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer’s disease patients

  2020cites this paper
• Genetic architecture of Alzheimer's disease.

  2020cites this paper
• Alternatives to amyloid for Alzheimer's disease therapies—a symposium report

  2020cites this paper
• DNA methylation in APOE: The relationship with Alzheimer's and with cardiovascular health

  2020cites this paper
• Epigenome‐wide analyses identify DNA methylation signatures of dementia risk

  2020cites this paper
• Genomics of Alzheimer’s disease

  2020cites this paper
• Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM genes in the blood of Alzheimer's disease patients

  2020cites this paper
• DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer disease.

  2020cites this paper
• Alzheimer’s disease risk gene BIN1 induces Tau-dependent network hyperexcitability

  2020cites this paper
• Complications in Orthognathic Surgery

  2020cites this paper
• Differential Methylation Levels in CpGs of the BIN1 Gene in Individuals With Alzheimer Disease

  2019cites this paper
• Relationship between Alzheimer's disease-associated SNPs within the CLU gene, local DNA methylation and episodic verbal memory in healthy and schizophrenia subjects.

  2019cites this paper
• The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics

  2019cites this paper
• Omics and Epigenetics of Polyphenol-Mediated Neuroprotection: The Curcumin Perspective

  2019cites this paper
• Bioinformatics strategy to advance the interpretation of Alzheimer's disease GWAS discoveries: The roads from association to causation

  2019cites this paper
• How accurate is digital-assisted Le Fort I maxillary osteotomy? A three-dimensional perspective.

  2019cites this paper
• A concise review of human brain methylome during aging and neurodegenerative diseases

  2019cites this paper
• DNA methylation changes in infants between 6 and 52 weeks

  2019cites this paper
• DNA methylation in the APOE gene: its link with Alzheimer’s and cardiovascular health

  2019cites this paper
• Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease.

  2019cites this paper
• Evaluating the role of genetic variation in the epigenome in health and disease

  2018cites this paper
• Epigenetic analysis of human postmortem brain tissue.

  2018cites this paper
• Apolipoprotein E DNA methylation and late-life disease

  2018cites this paper
• Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics.

  2018cites this paper
• DNA methylation in the APOE genomic region is associated with cognitive function in African Americans

  2018cites this paper
• Epigenetic characterisation of ANK1, a novel gene implicated in Alzheimer’s disease (AD)

  2018cites this paper
• Epigenetics of chronic inflammatory diseases

  2018cites this paper
• Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

  2018cites this paper
• Religious Orders Study and Rush Memory and Aging Project

  2018cites this paper
• DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer’s Disease: A Cross-Sectional Cohort Study

  2017cites this paper
• Methylomic profiling of cortex samples from completed suicide cases implicates a role for PSORS1C3 in major depression and suicide

  2017cites this paper
• Chapter 9 – Epigenomics of Alzheimer’s Disease

  2017cites this paper
• Epigenetic Modification of mitochondrial genes in Alzheimer's disease (AD)

  2017cites this paper
• Dementia and its comorbidities : genetic and epigenetic influences

  2017cites this paper
• DNA Modifications and Alzheimer's Disease.

  2017cites this paper
• Driver or Passenger: Epigenomes in Alzheimer’s Disease

  2017cites this paper
• Multiregional analysis of global 5‐methylcytosine and 5‐hydroxymethylcytosine throughout the progression of Alzheimer's disease

  2017cites this paper
• Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives.

  2017cites this paper
• The epigenome in Alzheimer’s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism

  2016cites this paper
• Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer’s Model

  2016cites this paper
• Uncovering the Role of the Methylome in Dementia and Neurodegeneration.

  2016cites this paper
• Liver X Receptor Agonist Modifies the DNA Methylation Profile of Synapse and Neurogenesis-Related Genes in the Triple Transgenic Mouse Model of Alzheimer’s Disease

  2015cites this paper
• Microglial malfunction: the third rail in the development of Alzheimer's disease.

  2015cites this paper
• The Brain Fights Back: New Approaches to Mitigating Cognitive Decline.

  2015cites this paper
• Epigenomics of Alzheimer's disease.

  2015cites this paper
• Folic Acid Alters Methylation Profile of JAK-STAT and Long-Term Depression Signaling Pathways in Alzheimer’s Disease Models

  2015cites this paper